{"symbol": "EIDX", "companyName": "Eidos Therapeutics Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "https://www.eidostx.com", "description": "Eidos Therapeutics Inc is a clinical development-stage biopharmaceutical company. It is focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR.", "CEO": "Neil Kumar", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}